Indofarma Tbk. vs Kalbe Farma Tbk — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Kalbe Farma Tbk trades at Rp735 (market cap 35.34T, 108.3M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 90.5× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.
| INAF | KLBF | |
|---|---|---|
Market Cap | 390.51B | 35.34T |
Volume | — | 108.3M |
Lot | — | 1.08M |
Turnover | — | 80.02B |
Average Price | — | 738.89 |
Value | — | 80.02B |
Indicative Equilibrium Price | — | 735 |
Indicative Equilibrium Volume | — | 59.74K |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →